Results 201 to 210 of about 105,968 (369)
Prediabetes Associates With Musculoskeletal Alterations Independent of Total Body Adiposity
ABSTRACT Background Excess adiposity is a major risk factor for insulin resistance, prediabetes, and Type 2 diabetes and increases the risk for sarcopenia and osteosarcopenia later in life. It has been proposed that altered metabolic function and musculoskeletal status in people with obesity are directly linked, presumably because they share common ...
Alan Fappi +10 more
wiley +1 more source
ObjectivesData have indicated low to non-existent increased mortality risk for individuals with prediabetes, but it is unclear if the risk is increased when the patient has elevated iron markers. Our purpose was to examine the mortality risk among adults
core
ABSTRACT Introduction/Aims To study the association of risk factors with axonal degeneration, based on below‐threshold sural nerve amplitudes, as a proxy for distal symmetric polyneuropathy (DSP). In particular, to assess the differential contribution of risk factors in diabetes status subgroups.
Jurriaan J. A. Hodzelmans +6 more
wiley +1 more source
Fisiopatología y progresión de las personas con prediabetes [PDF]
Roberto González Suárez +1 more
openalex
Use of the Dietary Supplement 5‐Aminiolevulinic Acid (5‐ALA) and Its Relationship with Glucose Levels and Hemoglobin A1C among Individuals with Prediabetes [PDF]
Beatriz L. Rodríguez +7 more
openalex +1 more source
Heartfelt intervention: A role for PVN oxytocin neurons in the prediabetic heart
The Journal of Physiology, EarlyView.
Grace K. Nielsen +2 more
wiley +1 more source
ABSTRACT Objective This study examined associations between CDC's 2022 extended BMI percentiles (BMIp) and cardiometabolic biomarkers. Methods Using electronic medical record data, we included patients aged 6–17 years with BMI ≥ 85th percentile who had at least one of the following: total cholesterol, low‐density lipoprotein cholesterol (LDL), high ...
Samantha L. Pierce +4 more
wiley +1 more source
Relation of Prediabetes and Thyroid Function Tests [PDF]
Nurhan SAYACA +2 more
openalex +1 more source
ABSTRACT Given the high prevalence of the population who have metabolic dysfunction‐associated steatohepatitis (MASH), interest is growing in MASH‐targeted treatments. However, currently, there has been only one regulatory approved drug for MASH (Rezdiffra).
Quyen Thi Tran +11 more
wiley +1 more source

